Interferon alfa-2b biosimilar (Amega Biotech)

干扰素α-2b生物类似药 (Amega Biotech)

Report date: 2023/05/05 17:34:38

Base Information

Drug NameInterferon alfa-2b biosimilar (Amega Biotech)

Drug Alias Name干扰素α-2b生物仿制药 (Amega Biotech)Interferon Alfa-2b biosimilar - Amega Biotech

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsMelanomaLymphoma, FollicularLeukemia, Hairy Cell +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmega Biotech

Active IndicationsN/A

Inactive IndicationsMelanomaLymphoma, FollicularLeukemia, Hairy Cell +[7]

ATC CodeL03AB05